RNA-Based Therapeutics and Their Expanding Market
RNA-based therapeutics have moved from experimental molecular biology to a rapidly expanding segment of the pharmaceutical industry. Advances in RNA chemistry, delivery technologies, and manufacturing scalability are enabling therapies that directly modulate gene expression rather than targeting proteins alone. This shift is reshaping drug development strategies across rare diseases, oncology, metabolic disorders, and infectious disease … Read more